JAN 22, 2016 12:20 PM PST

New Pathway of 'Microptosis' to Attack Parasitic Infections

WRITTEN BY: Kara Marker
Scientists discovered a process similar to apoptosis in T lymphocytes and natural killer (NK) cells when they attack intracellular parasites before they can spread to other cells during an infection. Researchers from the Boston Children’s Hospital Program in Cellular and Molecular Medicine call the pathway “microptosis.”
 

 
“What our work suggests is that you can drive programmed cell death even in microbes,” said senior study investigator Judy Lieberman, MD, PhD. “I think it's probably a really ancient pathway." The study was published recently in the journal Nature Medicine.
 
The researchers used both human and specially engineered mouse cells to visualize microptosis after infected the cells with three intracellular parasites:
  • Trypanosoma cruzi
  • Toxoplasma gondii
  • Leishmania major
They saw the immune cells produce three proteins – perforin, granulysin, and granzymes – upon infection with the parasites. By poking holes in the membrane of a cell infected with a parasite, perforin allows granulysin and granzymes to enter. Granulysin attacks the surface of the parasite while the granzymes kill the parasite from within. Specifically, granzymes interrupt metabolism within the mitochondria, blocking the parasite’s source of power. After toxic reactive oxygen species build up, the DNA material shrinks and the membrane deteriorates. All three of the proteins are required for successful microptosis.
 
"While the parasitic enzymes that microptosis acts on are similar to mammalian enzymes," Leiberman said, "they are different enough that it should be relatively easy to develop drugs that target them and leave a patient's cells alone."
 
Indeed, when the body’s killer immune cells are overwhelmed with a particularly immense infection of parasites, boosting the microptotic action of the team of proteins with drug injections could prevent dangerous spread of parasitic infections.
 

Source: Boston Children's Hospital
 
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAR 13, 2020
Immunology
MAR 13, 2020
Malaria drug treats lupus and prevents diabetes
A drug commonly used to treat certain types of malaria has been found to have some surprising synergistic effects: havin ...
MAR 17, 2020
Immunology
MAR 17, 2020
What's the deal with SARS-CoV-2's spike protein?
Structurally, SARS-CoV-2 (the virus that causes COVID-19) are spherical shells consisting of a lipid membrane, with a co ...
MAR 28, 2020
Drug Discovery & Development
MAR 28, 2020
The Antibody Test to See if You've Already Had the Coronavirus
Knowing whether you’ve had the virus or not may not just reduce your need to panic- but also better help epidemiol ...
APR 22, 2020
Drug Discovery & Development
APR 22, 2020
Only 3% of COVID-19 Antibody Tests Approved by FDA
So far, only 3% of at least 90 COVID-19 antibody tests in the US have been approved by the Food and Drug Administration ...
MAY 07, 2020
Cell & Molecular Biology
MAY 07, 2020
How the Function of a Critical Immune Cell is Related to Metabolism
This work suggests that it may be possible to dampen autoimmunity or promote an immune attack on cancer through a bioche ...
MAY 15, 2020
Immunology
MAY 15, 2020
Support the Microbiome So the Immune System Can Do Its Job
Research has long connected the human microbiome and immune system function, and now a recent study pinpoints a key poin ...
Loading Comments...